Jackson MW - Search Results

1

Using interferon-beta to combat cancer stem cell properties in triple negative breast cancer.

Doherty MR, Jackson MW. Doherty MR, et al. Among authors: jackson mw. Oncoscience. 2018 Jun 28;5(5-6):169-171. doi: 10.18632/oncoscience.438. eCollection 2018 May. Oncoscience. 2018. PMID: 30035180 Free PMC article. No abstract available.

2

Cancer Stem Cell Plasticity Drives Therapeutic Resistance.

Doherty MR, Smigiel JM, Junk DJ, Jackson MW. Doherty MR, et al. Among authors: jackson mw. Cancers (Basel). 2016 Jan 5;8(1):8. doi: 10.3390/cancers8010008. Cancers (Basel). 2016. PMID: 26742077 Free PMC article. Review.

3

Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.

Doherty MR, Cheon H, Junk DJ, Vinayak S, Varadan V, Telli ML, Ford JM, Stark GR, Jackson MW. Doherty MR, et al. Among authors: jackson mw. Proc Natl Acad Sci U S A. 2017 Dec 26;114(52):13792-13797. doi: 10.1073/pnas.1713728114. Epub 2017 Dec 11. Proc Natl Acad Sci U S A. 2017. PMID: 29229854 Free PMC article.

4

The Critical, Clinical Role of Interferon-Beta in Regulating Cancer Stem Cell Properties in Triple-Negative Breast Cancer.

Doherty MR, Jackson MW. Doherty MR, et al. Among authors: jackson mw. DNA Cell Biol. 2018 Jun;37(6):513-516. doi: 10.1089/dna.2018.4247. Epub 2018 May 11. DNA Cell Biol. 2018. PMID: 29750542 Free PMC article.

5

The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer.

Doherty MR, Parvani JG, Tamagno I, Junk DJ, Bryson BL, Cheon HJ, Stark GR, Jackson MW. Doherty MR, et al. Among authors: jackson mw. Breast Cancer Res. 2019 Apr 29;21(1):54. doi: 10.1186/s13058-019-1136-x. Breast Cancer Res. 2019. PMID: 31036052 Free PMC article.

6

Silencing the roadblocks to effective triple-negative breast cancer treatments by siRNA nanoparticles.

Parvani JG, Jackson MW. Parvani JG, et al. Among authors: jackson mw. Endocr Relat Cancer. 2017 Apr;24(4):R81-R97. doi: 10.1530/ERC-16-0482. Epub 2017 Feb 1. Endocr Relat Cancer. 2017. PMID: 28148541 Free PMC article. Review.

7

How cancer cells make and respond to interferon-I.

Cheon H, Wang Y, Wightman SM, Jackson MW, Stark GR. Cheon H, et al. Among authors: jackson mw. Trends Cancer. 2023 Jan;9(1):83-92. doi: 10.1016/j.trecan.2022.09.003. Epub 2022 Oct 8. Trends Cancer. 2023. PMID: 36216730 Free PMC article. Review.

8

Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling.

Junk DJ, Bryson BL, Smigiel JM, Parameswaran N, Bartel CA, Jackson MW. Junk DJ, et al. Among authors: jackson mw. Oncogene. 2017 Jul 13;36(28):4001-4013. doi: 10.1038/onc.2017.33. Epub 2017 Mar 13. Oncogene. 2017. PMID: 28288136 Free PMC article.

9

HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss.

Bartel CA, Jackson MW. Bartel CA, et al. Among authors: jackson mw. PLoS One. 2017 May 2;12(5):e0176778. doi: 10.1371/journal.pone.0176778. eCollection 2017. PLoS One. 2017. PMID: 28463969 Free PMC article.

10

Targeting Pancreatic Cancer Cell Plasticity: The Latest in Therapeutics.

Smigiel JM, Parameswaran N, Jackson MW. Smigiel JM, et al. Among authors: jackson mw. Cancers (Basel). 2018 Jan 10;10(1):14. doi: 10.3390/cancers10010014. Cancers (Basel). 2018. PMID: 29320425 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168 results

Search Page